El Cerrito, California

Soft Opening Begins September 9, 2026

Opening, in measured doses.

Beginning September 9, 2026, we'll begin compounding a limited formulary while we finalize our DEA registration. Our full formulary is expected roughly four to six weeks after that.

Curious what's ahead? Browse our full site to see the complete range of therapeutic categories we'll offer once our DEA registration is finalized.

Your subscription could not be saved. Please try again.
Your request has been recorded. You will be notified when our DEA registration is complete.

Be the first to know

We'll notify you as soon as our DEA registration is complete and our full formulary (controlled substances and capsules) is available.

What We're Compounding Today

A limited formulary while we complete our DEA registration.

Women's Health

  • Estrogen creams & suppositories
  • Progesterone creams & suppositories
  • Arousal creams (theophylline/arginine/sildenafil)
  • Boric acid suppositories

Men's Health

  • ED troches — tadalafil, sildenafil, PT-141, and oxytocin combinations

Dermatology

  • Hyperpigmentation preparations
  • Acne preparations
  • Topical hair formulations
  • Numbing creams

GI & Colorectal

  • Lidocaine / nifedipine ointments
  • Nitroglycerin ointments
  • Pelvic floor suppositories (non-controlled)

Postpartum Care

  • APNO (all-purpose nipple ointment)
  • Lidocaine / nifedipine ointments

Pediatrics

  • Pediatric suspensions
  • Petite suppositories
  • Topical creams and ointments

Supportive Care

  • Magic mouthwash

Veterinary

No controlled substances or capsules at this time. Our full range of therapeutic categories and dosage forms will open as our DEA registration is finalized.